SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-162442
Filing Date
2017-05-08
Accepted
2017-05-08 15:06:27
Documents
64
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d272250d10q.htm 10-Q 531772
2 EX-31.1 d272250dex311.htm EX-31.1 6949
3 EX-31.2 d272250dex312.htm EX-31.2 7347
4 EX-31.3 d272250dex313.htm EX-31.3 7625
5 EX-32.1 d272250dex321.htm EX-32.1 4433
6 EX-32.2 d272250dex322.htm EX-32.2 4628
7 EX-32.3 d272250dex323.htm EX-32.3 4407
  Complete submission text file 0001193125-17-162442.txt   2993312

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT cfrx-20170331.xml EX-101.INS 436738
9 XBRL TAXONOMY EXTENSION SCHEMA cfrx-20170331.xsd EX-101.SCH 43539
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cfrx-20170331_cal.xml EX-101.CAL 47931
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cfrx-20170331_def.xml EX-101.DEF 131876
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE cfrx-20170331_lab.xml EX-101.LAB 316904
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cfrx-20170331_pre.xml EX-101.PRE 230562
Mailing Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701
Business Address 28 WELLS AVENUE 3RD FLOOR YONKERS NY 10701 914-207-2300
CONTRAFECT Corp (Filer) CIK: 0001478069 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36577 | Film No.: 17821904
SIC: 2834 Pharmaceutical Preparations